ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
HU
Hanyang University at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hanyang University takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on lung cancer, from bispecific T-cell engager and CAR T-cell therapies in small cell lung cancer to treatment after first-line therapy stops working in non-small cell lung cancer. It also covers the biology and testing of tumours with ROS1 gene fusions.
| Organization | ESMO 2026 Attendance |
|---|---|
HU Hanyang University Seoul, Republic of Korea | |
Private university in Seoul, South Korea, with a college of medicine and university hospitals. | Chair Fri Oct 23 13:30–15:00 SCLC: Can we finally tackle it? Lung & thoracic cancers Talk Fri Oct 23 13:45–14:00 When and how to BiTE SCLC and CAR-T? Lung & thoracic cancers Satellite Fri Oct 23 18:15–19:45 AstraZeneca - Advancing excellence in lung cancer: New biomarkers, novel combinations, and changing standards of care Lung & thoracic cancersBiomarkers & precision oncology Satellite Fri Oct 23 18:15–18:20 Welcome and introductions Lung & thoracic cancersBiomarkers & precision oncology Satellite Fri Oct 23 19:00–19:15 Transforming the NSCLC landscape to improve outcomes after progression on 1L therapy Lung & thoracic cancersBiomarkers & precision oncology Talk Sun Oct 25 18:45–19:05 Biology insights and optimal testing strategies for patients with ROS1-fused solid tumours Lung & thoracic cancers |
Find decision makers at Hanyang University
Tell us what you sell and we’ll find the people at Hanyang University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction